| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/25/2007 | CN1954073A Modified Bouganin proteins, cytotoxins and methods and uses thereof |
| 04/25/2007 | CN1953990A Cyclopeptide derivatives with anti-integrin activity |
| 04/25/2007 | CN1953989A Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents |
| 04/25/2007 | CN1953988A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 04/25/2007 | CN1953765A An agent comprising fgf2 as an effective ingredient for treatment or prevention of asthma and chronic obstructive pulmonary disease |
| 04/25/2007 | CN1953764A Type II diabetes |
| 04/25/2007 | CN1953763A Y4 selective receptor agonists for therapeutic interventions |
| 04/25/2007 | CN1953762A Sensitization to another anticancer therapy and/or amelioration of a side effect of another anitcancer therapy by treatment with a GST-activated anticancer compound |
| 04/25/2007 | CN1953738A Effervescent formulations comprising desmopressin |
| 04/25/2007 | CN1953733A Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GnRH |
| 04/25/2007 | CN1952166A Important controlling gene PIX in anti-tumor immunological reaction |
| 04/25/2007 | CN1952165A Use of pp3774 gene in inhibiting cell growth |
| 04/25/2007 | CN1952146A Expression separation and purification method for Chinese Phytolacca acinosa cDNA mutant and TAT gene recombinant in prokaryon and application therefor |
| 04/25/2007 | CN1952135A Polynucleotide related to cell multiplication and its encoded polypeptide and application |
| 04/25/2007 | CN1952134A Polynucleotide promoting activity of human transcription factor NF-kappa B and its encoded polypeptide and application |
| 04/25/2007 | CN1952133A Polynucleotide activating ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952132A Polynucleotide having influence on ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952127A Application of BPY2IP1 gene in inhibiting CRE activation |
| 04/25/2007 | CN1952123A Method for improving expression efficiency of lumbru kinase component F-III in yeast |
| 04/25/2007 | CN1951965A Glp－1衍生物 Glp-1 derivatives |
| 04/25/2007 | CN1951961A Human Prox1 protein and its uses for resisting hepatitis B infection |
| 04/25/2007 | CN1951957A Gene MgPTH12 for controlling mature and pathogenicity of fungi appressorium derived from Magnaporthe grisea and its uses |
| 04/25/2007 | CN1951955A Peptide-like endothelin receptor antagonist with proline or cyclic amino acid on 2-postion |
| 04/25/2007 | CN1951496A Use of long-acting human recombined soluble TNF alpha receptor in preparation of medicament for treating liver failure |
| 04/25/2007 | CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 04/25/2007 | CN1951371A Immediate release tablet |
| 04/25/2007 | CN1312908C Digital camera |
| 04/25/2007 | CN1312279C Method for preparing elspar modilfied by carbowax |
| 04/25/2007 | CN1312178C High density lipoprotein-reactive peptides |
| 04/25/2007 | CN1312176C Buthotoxin polypeptide and preparation method thereof |
| 04/25/2007 | CN1312175C Trichosanthin mutant and coding gene thereof |
| 04/25/2007 | CN1312140C Lipid lowering biphenylcarboxamides |
| 04/25/2007 | CN1311870C Interleukin 6 production inhibitor |
| 04/25/2007 | CN1311869C Biological collagen injection as substituted blood plasma and its preparation method |
| 04/25/2007 | CN1311868C Preparing process of insulin powder inhalant |
| 04/25/2007 | CN1311867C Nerve growth factor (NGF) preparation administered via nasal cavity |
| 04/25/2007 | CN1311866C Use of erythopoietin |
| 04/25/2007 | CN1311865C Prolonged delivery of peptides |
| 04/24/2007 | USRE39587 Malleable paste for filling bone defects |
| 04/24/2007 | USRE39586 Secreted by the hybridoma cell line deposited in the Cell; Peripheral blood lymphocytes are activated in vitro with pokeweed mitogen and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies |
| 04/24/2007 | USRE39585 Administering streptococcus thermophilus in admixture withLactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum or Bifidobacterium breve |
| 04/24/2007 | US7208655 A plant virus containing a predetermined foreign peptide as part of the coat protein of the virus |
| 04/24/2007 | US7208612 Crystals of LuxP and complexes thereof |
| 04/24/2007 | US7208600 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
| 04/24/2007 | US7208595 enzyme inhibitors cmprising cyclic peptides or peptide antibiotics used for treatment of drug resistant bacterial infections |
| 04/24/2007 | US7208589 Flea ultraspiracle nucleic acid molecules and uses thereof |
| 04/24/2007 | US7208584 Fibroblast growth factor-13 |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208578 Polynucleotide and polypeptide molecules for zacrp2, a novel member of the family of proteins bearing a collagen-like domain and a C1q domain |
| 04/24/2007 | US7208577 Methods of increasing lean tissue mass using OB protein compositions |
| 04/24/2007 | US7208576 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/24/2007 | US7208574 Host receptor for pathogenic bacteria |
| 04/24/2007 | US7208572 Modulation body weights; dietetics; eating disorders; polypeptide having specific amino acid sequence; amino acids is in the D-isoform |
| 04/24/2007 | US7208571 isolated cell containing a cyclic peptide having three amino acids, and one of such amino acids is a Ser, Thr or Cys |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208478 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/24/2007 | US7208476 Use of pseudopeptide analogs which inhibit insect juvenile hormone biosynthesis and the use of such analogs for insect control |
| 04/24/2007 | US7208475 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 04/24/2007 | US7208474 Bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 04/24/2007 | US7208473 Comprises colony stimulating factors for prevention and treatment of cell proliferative and differentiative disorders |
| 04/24/2007 | US7208472 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altered pharmacological properties |
| 04/24/2007 | US7208471 Glycopeptide phosphonate derivatives |
| 04/24/2007 | US7208470 Treating testicular cancer, ovarian cancer, prostate cancer with a biodrug protein; activin binding activity; hormone inhibitor |
| 04/24/2007 | US7208469 Administering adrenomedullin for stimulate chondrocyte proliferation; treatment of cartilage defects, bone disorders, growth disorders; biodrugs |
| 04/24/2007 | US7208468 Radiolabelled shiga-like toxins as ANTITUMOR AGENTS for treating ovarian, breast, and brain tumors; imaging a tumor in a mammal |
| 04/24/2007 | US7208467 Administering a compound altering transfer of cholesterol or cholesteryl ester from high density lipoprotein or other lipoproteins via SR-BI to liver or steroidogenic tissues or compounds blocking oxidative modification of LDL |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208311 chimeric protein; nucleic acids that encode them; expression vectors; gene therapy for treating respiratory system disorders |
| 04/24/2007 | US7208308 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2007 | US7208305 A purified polypeptide comprising a splice variant of AMP-activated kinase; improved metabolic regulation |
| 04/24/2007 | US7208301 Method for producing 6-0-α-D-glucopyranosyl-D-sorbitol |
| 04/24/2007 | US7208297 Nucleotide sequence encoding a polypeptide derived from fungus Thraustochytrium aureum; expression of vector results in production of polyunsaturated fatty acid (omega 6-docosapentaenoic acid and docosahexaenoic acid); use in pharmaceutical compositions, animal feeds and cosmetics |
| 04/24/2007 | US7208293 Directed evolution of novel binding proteins |
| 04/24/2007 | US7208292 Nucleic acid encoding an interleukin-9 receptor variant |
| 04/24/2007 | US7208291 Protein comprising cytoplasmic domain, membrane-spanning domain and an extracellular domain with biotin-binding activity; avidin activity; endocytosis |
| 04/24/2007 | US7208289 Receptor binding assay wherein binding to the CLLD8 protein identifies the compound as being an agonist or antagonist |
| 04/24/2007 | US7208288 Methods for enhancing the lysis of coagulated blood with apolipoprotein E2 phenotype |
| 04/24/2007 | US7208283 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 04/24/2007 | US7208280 Controlling gene expression in tissue |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208270 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening |
| 04/24/2007 | US7208267 Compositions and methods relating to breast specific genes and proteins |
| 04/24/2007 | US7208179 Preparing a supplemented tissue sealant, applying to patient |
| 04/24/2007 | US7208178 For facilitating the delivery of active agents, such as insulin, to a target |
| 04/24/2007 | US7208171 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 04/24/2007 | US7208167 Treatment of hepatitis C with thymosin and peptide combination therapy |
| 04/24/2007 | US7208166 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology |
| 04/24/2007 | US7208165 Human cytomegalovirus DNA sequences |
| 04/24/2007 | US7208156 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 04/24/2007 | US7208155 Agent for treating allergic or hypersensitivity condition |
| 04/24/2007 | US7208154 Methods and compositions for the treatment of MHC-associated conditions |
| 04/24/2007 | US7208153 Method for the improvement of neuronal regeneration |
| 04/24/2007 | US7208152 Antibodies for “Bonzo” chemokine receptor and therapeutic uses thereof |
| 04/24/2007 | US7208150 Non-toxic fraction isolated from the venom of Vipera xanthina, for therapy of pain |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | US7208148 Chemically modified cytokines |
| 04/24/2007 | US7208147 Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity |
| 04/24/2007 | CA2374091C The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 04/24/2007 | CA2277832C Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
| 04/24/2007 | CA2268741C Uses of keratinocyte growth factor-2 |